Partnership

Sea Pharma develops own product dossiers or in-license already available dossiers for registration which, after Regulatory approval, are launched to the market. We are open for all kinds of cooperation related to this strategy. It can be to take the full MAH (Marketing Authorisation Holder) responsibility with the necessary local infrastructure related to acting as MAH, including distribution and requirements related to GDP (Good Distributional Practice) for companies who are looking for licensees. It can also be to fill the gaps for partly developed pharmaceutical projects necessary to reach the requirements for regulatory approval. 

We can act as local representative for companies who have registrations available as MAH but do not have the local presence in the Nordic countries. 

​

​